US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 268 actively recruiting studies with Colorado sites out of 268 registered in total. The busiest research areas in Colorado are Breast Cancer, Colorectal Cancer, Aging. Leading sponsors running trials in the state include University of Colorado, Denver, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Colorado trials break down as Phase 1 (38), Phase 2 (60), Phase 3 (75), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
268
Recruiting Now
268
← Back to US Map
Top Conditions in Colorado
Breast Cancer (11)Colorectal Cancer (6)Aging (5)Metastatic Breast Cancer (4)Ovarian Cancer (4)Gastric Cancer (4)Esophageal Adenocarcinoma (4)Prostate Cancer (4)Surgery (3)Colorectal Carcinoma (3)Ovarian Carcinoma (3)Colon Cancer (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 268 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 268. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Aging, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
View Trial →
NCT03517761 N/A
Recruiting
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse ...
Condition
Craniocervical Injuries
Enrollment
80 pts
Location
United States
Sponsor
Regenexx, LLC
View Trial →
NCT05454969 N/A
Recruiting
One-4-ALL Initiative
Condition
Literacy
Enrollment
100 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT01950624 N/A
Recruiting
DS-Connect®: The Down Syndrome Registry
Condition
Down Syndrome
Enrollment
100,000 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07335562 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleu...
Condition
Systemic Sclerosis
Enrollment
92 pts
Location
United States, Belgium, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT04184973 N/A
Recruiting
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Condition
Rectal Cancer
Enrollment
250 pts
Location
United States, Germany, Israel
Sponsor
Colospan Ltd.
View Trial →
NCT06383273 Phase 3
Recruiting
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in S...
Condition
Cataract
Enrollment
528 pts
Location
United States
Sponsor
Melt Pharmaceuticals
View Trial →
NCT05937854 Phase 2
Recruiting
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
126 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT05254041 N/A
Recruiting
Pilot Study of Suction as a Mechanism of IUD Expulsion With Concomitant Menstrua...
Condition
IUD; Complications, Mechanical
Enrollment
80 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04900818 Phase 1
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tum...
Condition
Solid Tumor
Enrollment
330 pts
Location
United States, China
Sponsor
I-Mab Biopharma US Limited
View Trial →
NCT04986423 Phase 2
Recruiting
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castrat...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
200 pts
Location
United States, China
Sponsor
Zenith Epigenetics
View Trial →
NCT07409103 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat ...
Condition
Active Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, South Africa
Sponsor
Elevara Medicines Limited
View Trial →
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Condition
Advanced Solid Tumor
Enrollment
140 pts
Location
United States, United Kingdom
Sponsor
Nuvectis Pharma, Inc.
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07225751 N/A
Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Asses...
Condition
Ankle Arthrodesis or Arthroplasty
Enrollment
126 pts
Location
United States
Sponsor
Kuros Biosurgery AG
View Trial →
NCT06455449 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Su...
Condition
Polymyositis, Dermatomyositis
Enrollment
240 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT03526835 Phase 1, Phase 2
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Condition
Advanced/Metastatic Solid Tumors
Enrollment
523 pts
Location
United States, Belgium, France
Sponsor
Merus B.V.
View Trial →
NCT06754150 N/A
Recruiting
Shoulder Innovations Clinical Data Registry
Condition
Shoulder Arthroplasty
Enrollment
2,500 pts
Location
United States
Sponsor
Shoulder Innovations
View Trial →
NCT04911491 N/A
Recruiting
Inspiratory Muscle Strength Training in Chronic Kidney Disease
Condition
Chronic Kidney Diseases
Enrollment
108 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07185997 Phase 3
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigato...
Condition
Non-Small-Cell Lung Cancer
Enrollment
480 pts
Location
United States, Australia, Canada
Sponsor
ArriVent BioPharma, Inc.
View Trial →
NCT05530343 N/A
Recruiting
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients Wi...
Condition
Barrett Esophagus
Enrollment
2,298 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
Page 2 of 11 — 268 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology